Registry for coronary and small-vessel heart disease in cardiomyopathy
Part of Genetic & congenital, Heart & circulation clinical trials.
This study enrolls people with certain types of heart muscle diseases to learn how blocked heart arteries and tiny blood vessels affect symptoms and outcomes. It may help researchers better understand these conditions and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart muscle disease in one of these types: ischemic, dilated, hypertrophic, or restrictive
- Your condition involves coronary (heart artery) disease and/or coronary microvascular (tiny vessel) disease
- You are not pregnant
- You are not breastfeeding
- You are able to participate without being under legal protection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who have been newly diagnosed with heart failure to find rare forms of heart muscle disease (cardiomyopathy) early and start the right treatment. It uses advanced heart imaging (CMR) and requires that you have not had heart problems before.
This study looks at genetic (DNA) changes that may cause cardiomyopathy, a disease where the heart muscle is weakened. It may help families understand possible causes and inform future care.
This study builds a patient registry to collect information over time about several types of cardiomyopathy (heart muscle diseases). It may help researchers understand how these conditions progress and what care works best.
This study creates a registry (a detailed record) for people with hypertrophic cardiomyopathy, a condition where the heart muscle is thicker than normal. It aims to learn more about the condition over time.
This program builds a registry of people diagnosed with hypertrophic cardiomyopathy and their family members. By collecting health information over time, researchers hope to better understand the condition and improve care.
This study collects information from heart MRIs of people with hypertrophic cardiomyopathy, a condition where the heart muscle is unusually thick. The registry looks at how a special dye (gadolinium) highlights scarring in the heart, which may help doctors better understand and treat this condition.
Hear when a new Ischemic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.